General

  • Target

    https://braeburnrx.com/braeburns-brixadi-buprenorphine-extended-release-subcutaneous-injection-ciii-receives-fda-approval-for-moderate-to-severe-opioid-use-disorder/

Score
1/10

Malware Config

Signatures

Files